Nan-Offeringa L - Search Results

1

An excretion balance and pharmacokinetic study of the novel anticancer agent E7070 in cancer patients.

van sen Bongard HJ, Pluim D, Rosing H, Nan-Offeringa L, Schot M, Ravic M, Schellens JH, Beijnen JH. van sen Bongard HJ, et al. Among authors: nan offeringa l. Anticancer Drugs. 2002 Sep;13(8):807-14. doi: 10.1097/00001813-200209000-00004. Anticancer Drugs. 2002. PMID: 12394264

2

Quantitative determination of the novel anticancer drug E7070 (indisulam) and its metabolite (1,4-benzenedisulphonamide) in human plasma, urine and faeces by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.

Beumer JH, Rosing H, Hillebrand MJ, Nan-Offeringa LG, Foley K, Yule SM, Heck AJ, Schellens JH, Beijnen JH. Beumer JH, et al. Among authors: nan offeringa lg. Rapid Commun Mass Spectrom. 2004;18(23):2839-48. doi: 10.1002/rcm.1699. Rapid Commun Mass Spectrom. 2004. PMID: 15517526

3

Quantitative analysis of D-24851, a novel anticancer agent, in human plasma and urine by liquid chromatography coupled with tandem mass spectrometry.

Stokvis E, Nan-Offeringa LG, Ouwehand M, Tibben MM, Rosing H, Schnaars Y, Grigat M, Romeis P, Schellens JH, Beijnen JH. Stokvis E, et al. Among authors: nan offeringa lg. Rapid Commun Mass Spectrom. 2004;18(13):1465-71. doi: 10.1002/rcm.1493. Rapid Commun Mass Spectrom. 2004. PMID: 15216507

4

Quantitative analysis of ES-285, an investigational marine anticancer drug, in human, mouse, rat, and dog plasma using coupled liquid chromatography and tandem mass spectrometry.

Stokvis E, Nan-Offeringa L, Rosing H, López-Lázaro L, Aceña JL, Miranda E, Lyubimov A, Levine BS, D'Aleo C, Schellens JH, Beijnen JH. Stokvis E, et al. Among authors: nan offeringa l. J Mass Spectrom. 2003 May;38(5):548-54. doi: 10.1002/jms.469. J Mass Spectrom. 2003. PMID: 12794877

5

Development and validation of a liquid chromatography-tandem mass spectrometry assay for the quantification of lurbinectedin in human plasma and urine.

van Andel L, Rosing H, Lubomirov R, Avilés P, Fudio S, Tibben MM, Nan-Offeringa L, Schellens JHM, Beijnen JH. van Andel L, et al. Among authors: nan offeringa l. J Pharm Biomed Anal. 2018 Sep 5;158:160-165. doi: 10.1016/j.jpba.2018.05.053. Epub 2018 Jun 1. J Pharm Biomed Anal. 2018. PMID: 29883879

6

Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.

Crommentuyn KM, Rosing H, Nan-Offeringa LG, Hillebrand MJ, Huitema AD, Beijnen JH. Crommentuyn KM, et al. Among authors: nan offeringa lg. J Mass Spectrom. 2003 Feb;38(2):157-66. doi: 10.1002/jms.425. J Mass Spectrom. 2003. PMID: 12577282

7

Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients.

Aviles P, Altares R, van Andel L, Lubomirov R, Fudio S, Rosing H, Márquez Del Pino FM, Tibben MM, Benedit G, Nan-Offeringa L, Luepke Estefan XE, Francesch A, Zeaiter A, Cuevas C, Schellens JHM, Beijnen JH. Aviles P, et al. Among authors: nan offeringa l. Drug Metab Dispos. 2022 Apr;50(4):327-340. doi: 10.1124/dmd.121.000668. Epub 2022 Jan 18. Drug Metab Dispos. 2022. PMID: 35042701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters